Company intelligence / Profile preview
CKD OTTO Pharma
Jakarta/South Jakarta City/Setiabudi/Karet Kuningan, Jakarta Special Capital Region, Indonesiackd-otto.com ↗
- Ownership
- Private
- Employees
- ~125
- Development stage
- Other
01
Overview
CKD OTTO Pharma manufactures and markets a portfolio of oncology drugs in Indonesia and exports to MENA, GCC, ASEAN, and East Asia. The company has received GMP certification from Indonesian authorities as well as Halal certification for its oncology manufacturing. Its commercialized products include pemetrexed ("Pemecine"), bortezomib ("Tezobell"), oxaliplatin ("Belloxa"), among others. The company also acts as a contract manufacturer for local partners.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Chong Kun Dang Pharm Corp.Otto Pharmaceutical Industries/MENSA Group
Beyond the preview
Go deeper on CKD OTTO Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CKD OTTO Pharma.